Yale Bulletin and Calendar

November 16, 2007|Volume 36, Number 11


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Team develops blood test
for deadly aneurysm disease

Yale scientists have discovered a way to use a simple blood test that may accurately detect thoracic aneurysm disease (TAA), which gives little warning and is almost always fatal if untreated.

The study, published this month in Public Library of Science (PLoS), represents the collaborative work of Yale School of Medicine, Applied Biosystems and Celera Diagnostics.

TAAs occur in the part of the aorta that passes through the chest. They can become huge without causing symptoms. In fact, only one in 20 patients has symptoms before internal rupture occurs — making advance detection key to treatment. Once the aneurysm ruptures, a person can go into shock and die from internal bleeding. Currently, detection of these aneurysms is made by relatively expensive tests such as a chest X-ray or CT scan — typically when a patient is being evaluated for other conditions.

“A standardized blood-based test capable of detecting individuals at risk for aneurysm disease would represent a major advance in clinical care,” says Dr. John Elefteriades, section chief of cardiothoracic surgery. “This study indicates we may be able to develop such a test.”

In this study, Elefteriades and his colleagues took blood samples from 58 persons diagnosed with TAA disease and 36 spouses who did not have the disease. Using a gene expression profiling technology, they identified a 41-gene signature in blood cells that distinguishes TAA patients from those without the disease. The gene expression signature and the prediction model were identified using a complete workflow of instruments, reagents and software from Applied Biosystems. These signature genes were further validated using TaqMan® real-time PCR assays. The accuracy rate in various analyses is 78% to 85%.

“It has become increasingly evident that the immune system plays a pivotal role in the development of aortic aneurysms,” Elefteriades says. “We thus hypothesized that gene expression patterns in peripheral blood cells may reflect TAA disease status.”

The next step, which the researchers say is underway, is validation in real-time clinical studies. The investigative team is also interested in determining if abdominal aneurysms share a similar RNA signature, and if the RNA can predict rupture or dissection of an aneurysm.

By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

Restoration of iconic Rudolph building is key step in . . . Arts Complex

Three faculty win nation’s highest award for beginning researchers

Bulldogs, Crimsons both bringing undefeated Ivy records . . .

A grateful nation

New technology allows view of protein interactions in living cells

Monkeys and children share adults’ tendency to rationalize choices

Noted composer Benjamin Lees donates his archive to Yale library

Museum joins with area public schools to promote ‘visual literacy’

A conversation in China leads to successful research collaboration

Junior faculty earn second terms in endowed posts

SCHOOL OF MEDICINE NEWS

Four decades of readers in Yale libraries are featured in exhibition

Video installations by Ori Gersht on view at British Art Center

Reception will celebrate United Way donors as campaign continues

Yale Books in Briefs

Benefit event to feature noted neurosurgeon

Workshop to feature Ohio State law professor

Reminder: Open enrollment period ends Nov. 18

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home